Olympus Expands Surgical Portfolio with FDA-Cleared POWERSEAL Open Extended Jaw Device
Event summary
- Olympus received FDA 510(k) clearance for the POWERSEAL Open Extended Jaw Sealer/Divider on April 28, 2026.
- The device is designed for open surgery, complementing Olympus's existing POWERSEAL portfolio of 5mm devices.
- Full market availability is expected in late Spring 2026.
- The device supports vessel sealing up to 7mm in diameter and features ergonomic design for single-handed use.
The big picture
Olympus's latest FDA clearance strengthens its position in the advanced bipolar surgical energy market. The POWERSEAL Open Extended Jaw Sealer/Divider adds to a portfolio already serving multiple surgical specialties, reflecting a strategic focus on precision and efficiency in open surgery. This expansion comes at a time when the medical technology sector is increasingly emphasizing minimally invasive and ergonomic solutions to enhance surgical outcomes.
What we're watching
- Market Adoption
- The pace at which the POWERSEAL Open Extended Jaw Sealer/Divider gains traction among surgeons in various specialties.
- Competitive Positioning
- How Olympus's expanded POWERSEAL portfolio will compete against established players in the surgical energy market.
- Regulatory Compliance
- Whether the device will face any post-market regulatory scrutiny given its single-use designation and potential risks.
Related topics